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Abstract
Background: Yersinia enterocolitica is a common cause of food borne gastrointestinal disease. After oral uptake,
yersiniae invade Peyer’s patches of the distal ileum. This is accomplished by the binding of the Yersinia invasin to
b1 integrins on the apical surface of M cells which overlie follicle associated lymphoid tissue. The gut represents a
barrier that severely limits yersiniae from reaching deeper tissues such as Peyer’s patches. We wondered if gut
protease attack on invasion factors could contribute to the low number of yersiniae invading Peyer’s patches.
Findings: Here we show that invasin is rapidly degraded in vivo by gut proteases in the mouse infection model.
In vivo proteolytic degradation is due to proteolysis by several gut proteases such as trypsin, a-chymotrypsin,
pancreatic elastase, and pepsin. Protease treated yersiniae are shown to be less invasive in a cell culture model.
YadA, another surface adhesin is cleaved by similar concentrations of gut proteases but Myf was not cleaved,
showing that not all surface proteins are equally susceptible to degradation by gut proteases.
Conclusions: We demonstrate that gut proteases target important Yersinia virulence factors such as invasin and
YadA in vivo. Since invasin is completely degraded within 2-3 h after reaching the small intestine of mice, it is no
longer available to mediate invasion of Peyer’s patches.
Background
Y. enterocolitica and Y. pseudotuberculosis cause food-
borne gastrointestinal disease in humans. While Y. pseu-
dotuberculosis is primarily an animal pathogen that only
rarely causes disease in humans, Y. enterocolitica is one
of the most common causes of gastroenteritis especially
in northern Europe where Y. enterocolitica is the third
most common cause of bacterial gastroenteritis [1]. Yer-
sinia infection can manifest as enteritis, terminal ileitis,
or mesenteric lymphadenitis (pseudoappendicitis) but
can occasionally lead to septicaemia with abscess forma-
tion in liver and spleen in predisposed patients (e.g. iron
overload). After several weeks, immunological sequelae
such as reactive arthritis or erythema nodosum may
complicate yersiniosis [1]. After oral uptake, yersiniae
are known to invade Peyer’s patches (PP) of the ileum
by entering through specialized epithelial cells called M
cells. This is made possible by the interaction of the
Yersinia invasin with b1 integrins which are expressed
on the luminal side of M cells but not enterocytes [2].
After translocation across the mucosal barrier, yersiniae
subsequently disseminate to lymph nodes, spleen and
liver where they form monoclonal microabscesses [3].
Invasin (Inv) is a chromosomally encoded outer mem-
brane protein which is expressed at low temperature and
early stationary phase, conditions which are prevalent in
stored foods [4,5]. Invasin is anchored by its N-terminal
region in the outer membrane. In Y. pseudotuberculosis
the C-terminal end forms an 18 angstrom rod consisting
of five globular domains (D1-D5) [6]. The C-terminal cell
adhesion superdomain (D4 and D5) is the minimal region
that is able to bind ab1 integrins [7,8]. High affinity bind-
ing by Y. pseudotuberculosis however also requires the
D2 domain, which is absent in Y. enterocolitica. D2 med-
iates oligomerization of Inv on the bacterial surface
which promotes the clustering of integrin receptors on
host cell membrane generating a critical signal that leads
to internalization of bacteria [9].
Another adhesin besides Inv, which is able to poten-
tially interact with b1 integrins of M cells is the pYV
plasmid encoded yadA, the prototype of a novel class of
nonfimbrial adhesins (the oligomeric coiled coil adhesin
family) [10,11]. YadA is a 41-44 kDa surface protein
that forms trimers in the outer membrane. These appear
as 23 nm lollipop-shaped projections consisting of an
18 nm stalk and a 5 nm head [12]. YadA binds diverse
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extracellular matrix (ECM) proteins such as collagen,
fibronectin and laminin [13,14]. Furthermore YadA
mediates indirect binding of yersiniae to b1 integrins
through fibronectin-b1 integrin bridging [15,16]. As is
the case for the Inv-b1 integrin interaction, the YadA-
fibronectin-b1 integrin bridging leads to IL-8 production
and to internalization of yersiniae by Hep-2 cells. These
effects are however short lived and are weaker than for
Inv [16]. YadA is a multifunctional protein [14] that is
responsible not only for adhesion and bacterial autoag-
glutination but also protects yersiniae from the actions
of defensins and confers resistance to serum comple-
ment lysis. Serum resistance is mediated by the stalk
domain whereas adherence to neutrophils and collagen
binding are mediated by the head region. A yadA knock
out mutant was highly attenuated both after oral and i.
v.- infection [17].
Invasin is the most important mediator of invasion
into Peyer’s patches in vivo but YadA and the attach-
ment-invasion locus protein (Ail) which mediates
attachment and invasion of eukaryotic cells in vitro are
further candidates that might play a role in vivo [18,19].
The chromosomally encoded myf (mucoid Yersinia fac-
tor) is similar to the pH 6 antigen of Y. pestis and is
composed of 15 kDa subunits that appear as a fibrillar
layer surrounding bacteria. Myf enhances binding to
cells and intestinal mucus [20]. We have recently dis-
covered that only very few yersiniae of a large inoculum
(109) invade Peyer’s patches from the gut lumen in the
mouse infection model [3]. We are now exploring
mechanisms that lead to this phenomenon. Since Inv,
YadA, and Myf are exposed on the bacterial surface,
they could be targets of gut proteases such as trypsin,
a-chymotrypsin, pancreatic elastase, carboxypeptidases
or pepsin. In fact Inv has been shown to be cleaved by
extracellular trypsin in vitro [21,22]. Proteolytic degrada-
tion of these proteins in the intestine would obviously
limit contact of Yersinia with M cells of the distal ileum
contributing to clonal invasion. Although it has been
shown that pathogenic bacteria are targeted by stomach
acid and defensins [23-26] in the GI tract, there are no
reports of the effects of gut proteases on virulence fac-
tors of enteric pathogens.
Methods
Bacterial strains and plasmids
Y. enterocolitica WA-314 is a clinical isolate of serotype
O:8 [27]. WA-C is a derivative of WA-314 [27] not har-
boring the pYV plasmid [3]. WA-C(pYV-kan) harbors a
kanamycin cassette in a non-coding region of the pYV
plasmid [3]. WA-C-inv and WA-314-inv are isogenic
invasin mutants of WA-C and WA-314 respectively
[28]. To construct a myfA mutant, a 645 bp myf-frag-
ment was subcloned and insertional inactivation of the
myfA gene was accomplished by introducing a spectino-
mycin resistance cassette amplified from Ω plasmid into
the internal KpnI restriction site of the myfA gene. The
myfA::spec construct was transferred to the suicide plas-
mid pEP185.2. This resulting mutator plasmid
pEP185.2myfA::spec was mobilized into strain WA-314
by conjugation from E. coli S17-1lpir, and the chromo-
somal myfA gene was replaced with the myfA::spec con-
struct by double recombination. Allelic exchange was
confirmed by PCR. Bacteria were cultured aerobically in
Luria-Bertani (LB) broth or on LB agar plates at 27°C.
Antibiotics were used at the following concentrations
(μg/ml); kanamycin: 25; chloramphenicol: 20, tetracy-
cline: 20.
Oral mouse infection
6-8 week old female Balb/c mice (Harlan-Winkelmann)
were kept under specific pathogen-free-conditions (posi-
tive-pressure cabinet) and were provided with food and
water ad libitum. Mice were infected orally with yersi-
niae grown to stationary phase in LB medium at 27°C.
Mice were sacrificed by CO2 asphyxiation and small
intestines were aseptically removed. Bacteria were
washed from the small intestines (SI) with PBS, and fil-
tered with a 5 μm Durapore filter (Millipore) to remove
debris. The number of yersiniae in the lavage was deter-
mined by plating serial dilutions on CIN agar. The indi-
cated number of yersiniae were subjected to SDS PAGE
on 11.5% polyacrylamide gel (Figure 1). Immunoblotting
was performed using nitrocellulose sheets. Blocking was
performed with 5% BSA in PBS overnight at 4°C. Poly-
clonal rabbit anti-Inv antiserum recognizing the 4 C-
terminal domains of Y. enterocolitica invasin and a
horseradish-peroxidase-conjugated secondary anti-rabbit
antibody were used for immunostaining. The rabbit a
Inv antibody was raised against a recombinant protein
containing the extracellular domains D1, D3, D4, and
D5 (C-terminal 397 AA) of Y. enterocolitica WA-314.
This region harbours the b1 integrin binding site but
not the membrane anchor. All mouse experiments were
approved by government authorities (Regierung von
Oberbayern, AZ 55.2-1-54-2531-153-07).
Adhesion and Invasion assays
HeLa cells were infected with yersiniae grown at 27°C at
MOIs of 50 in 24 well plates. Yersiniae were centrifuged
onto cells and incubated at 37°C for 90 min. Extracellu-
lar yersiniae were killed by addition of gentamicin (50
μg/ml) for 1 h. Cell lysis was performed with 0.1% tri-
ton/PBS. The number of intracellular and extracellular
bacteria was determined by plating serial dilutions of
bacteria on agar plates as described previously [29].
Adhesion assays were performed at 20°C, invasion
experiments at 37°C. Results are expressed as percent
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invasion (100 × CFU of Yersinia resistant to gentamicin/
cell associated bacteria). Plating serial dilutions of pro-
tease treated yersiniae demonstrated viability of yersiniae
after protease treatment. Bacteria treated with proteases
were not found to be hypersensitive to the Triton deter-
gent. Statistical analysis was performed using Mann-
Whitney test at the 0.05 significance level.
Protease digests
Yersiniae in Figure 2 lanes 11 and 12 were digested with
2,5 mg/ml trypsin in Tris-base pH 8.0, 11.5 mM CaCl2.
This is higher than concentrations of trypsin found in
intestinal fluid of humans [30]. Yersiniae in Figure 3
were digested with undiluted human ileal fluid. Yersiniae
in Figures 4, 5 and 6 were digested with trypsin (23 μg/ml
in Tris-base pH 8.0, 11.5 mM CaCl2), a-chymotrypsin
(20 μg/ml in 100 mM Tris/Cl pH 7.8, 10 mM CaCl2),
pancreatic elastase (10 μg/ml 100 mM NH4HCO3 pH
8.0) or carboxypeptidase A (50 μg/ml in 25 mM Tris/Cl
pH 7.65). These concentrations are below physiological
values which have been reported to be about 280 μg/g
feces, 450 μg/g feces, and 200 μg/g feces respectively
[30]. The pepsin digest in Figure 4a (4 mg/ml in 10
mM HCl) was performed using a concentration slightly
higher than that reported for human gastric juice of
0.5 -1 mg/ml [31]. All proteases were obtained from
Sigma-Aldrich.
107 yersiniae grown at 27°C in LB medium were
washed with PBS and digested at 37°C or 27°C in the
respective buffers. Following digestion for 1 h yersiniae
were harvested by centrifugation and subjected to
immunoblotting as described above. Yersiniae were also
digested with small intestinal secretions of Balb/c mice.
For this purpose, SI was washed with 3 ml PBS,
wt inv wt wt wtinv invinv





in vitro in vivo
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Figure 1 Proteolytic degradation of invasin in mouse small intestine. 5 Balb/c mice were infected orally with 109 CFU Y. enterocolitica WA-
314 (wt) or an isogenic inv mutant (inv). Mice were sacrificed at the indicated time points and bacteria were washed from small intestinal
lumen with PBS. For each lane 3 × 106 yersiniae were subjected to Western blotting with an a Inv polyclonal antibody. Solid arrowheads point
to full length Inv, arrowheads point to specific Inv degradation products.
wt inv
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Figure 2 In vitro proteolytic degradation of invasin. Y. enterocolitica WA-314 (wt) or the invasin mutant (inv) were digested for 2 h at 37°C
with small intestinal fluid of mice (SI) in different dilutions (1:10 - 1:10000). Digests with trypsin and trypsin digestion buffer (control) are also
shown. The small intestines of mice were washed with 2 ml trypsin digestion buffer, centrifuged, and the supernatant was used to digests 3 ×
106 CFU of yersiniae. Immunoblotting was performed with an a inv polyclonal antibody. Solid arrowheads point to full length Inv, open
arrowheads point to specific Inv degradation products.
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centrifuged and the supernatant was used for digests.
Protease inhibition was performed with a1 antitrypsin
(10 mg/ml).
Results
Inv is degraded in vivo by gut proteases
To determine if the surface exposed Yersinia virulence
factor invasin (Inv) is targeted by gut proteases in the
mouse infection model, we orally infected groups of five
Balb/c mice with 109 CFU Y. enterocolitica wild type
and an isogenic inv mutant. Bacteria were washed from
the lumen of the small intestine after 30 min, 1 h, 1.5 h,
and 2.5 h post infection and were subjected to Western
blotting using a polyclonal invasin antibody. As can be
seen in Figure 1 the 92 kDa full length Inv protein is
rapidly degraded in vivo. Only 30 min after oral infec-
tion of mice a significant amount of invasin is degraded
to a 49 kDa protein with only this degradation product
and no full length Inv remaining after 2.5 h. Several lar-
ger partial degradation products (open arrowheads) can
also bee seen in yersiniae cultured in vitro in the
absence of protease treatment (lane 1 of Figure 1, 2, 3
and 4). This is a well known phenomenon that has been
described previously [21,22]. To determine if Inv is sub-
sequently produced in the gut lumen, we performed
immunoblotting using the Inv antibody on yersiniae
washed from the SI of mice that were infected for 5
days. We could not detect full length protein or
degraded Inv by Western blotting (Figure 1). These
wt wt wtinv invinv wt invinv wt
5 min 15 min 30 min 1h 2h
80
47
Figure 3 Kinetics of proteolysis by human ileal fluid. 108 CFU Y.
enterocolitica WA-314 (wt) or the invasin mutant (inv) were digested
at 37°C for the indicated time with 1 ml human ileal fluid. For each
lane 3 × 106 yersiniae were subjected to Westerm blotting with an
a Inv polyclonal AB. Solid arrowheads point to full length Inv, open
arrowheads point to specific Inv degradation products.
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Figure 4 Serine proteases target invasin. (a) Wild-type Y. enterocolitica (wt) or the invasin mutant (inv) were digested with small intestinal
fluid from mice (SI), a-chymotrypsin (CT), trypsin (T), carboxypeptidase A (CP), pepsin (P), elastase (E) or trypsin digestion buffer (control) for 2 h
at 37°C. SI was washed with 2 ml PBS, centrifuged, and supernatant was used for digests. 1 × 107 CFU of yersiniae were subjected to Western
blotting with an a inv polyclonal AB. (b) Y. enterocolitica WA-314 (wt) or the invasin mutant (inv) were digested with the supernatant of small
intestinal luminal fluid (SI), mock digested with PBS or digested with SI preincubated with a1-antitrypsin for 1 h at 37°C. 1 × 107 CFU of yersiniae
were subjected to Western blotting with an a inv polyclonal AB. Solid arrowheads point to full length Inv, open arrowheads point to specific Inv
degradation products.
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results indicate that the major invasion factor of Yersi-
nia is degraded within a few hours after oral uptake by
gut proteases and is subsequently not produced in the
gut lumen at detectable levels. This presumably limits
Inv mediated early invasion of PPs by Yersinia to a very
short time window of a few hours only.
Inv is cleaved in vitro into 3 peptides
To determine if in vivo degradation could be reproduced
in vitro, we digested wild-type yersiniae grown in LB
medium at 27°C with serial dilutions (1:10-1:10000) of
SI fluid and trypsin for 2 h at 37°C (Figure 2). As a con-
trol, digests were performed with the inv mutant. This
experiment revealed that three distinct Inv degradation
products were generated by in vitro digestion of yersi-
niae with either concentrated or a 1:10 dilution of SI
luminal secretions. Complete digestion with a high tryp-
sin concentration revealed an identical peptide pattern.
Even when SI fluid was highly diluted (1:1000 -
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Figure 5 YadA but not Myf is degraded by gut proteases. Y. enterocolitica WA-314 (wt), yadA mutant (yadA) or Δmyf mutant were digested
with small intestinal (SI) luminal fluid, a-chymotrypsin (CT), trypsin (T), carboxypeptidase A (CP), pepsin (P), elastase (E) or trypsin digestion buffer
(control) for 2 h at 37°C. SI was washed with 2 ml PBS centrifuged and supernatant was used for digests. 1 × 107 CFU yersiniae were subjected
to Western blotting with a polyclonal YadA (a) or Myf (b) antibody. Solid arrowheads point to full length YadA, open arrowheads point to
































Figure 6 Gut protease treated yersiniae are less invasive in vitro. Y. enterocolitica WA-C or the invasin mutant WA-C-inv (Δinv) were digested
with the supernatant of small intestinal luminal fluid (SI) or trypsin or mock digested with trypsin digestion buffer. Invasion (a) and adhesion (b)
assays were performed using HeLa cells. Invasion assay was performed at 37°C, adhesion assay at 20°C. Percent yersiniae surviving gentamicin
treatment is shown in (a), Percent yersiniae adhering to cells and SD is shown in (b). Statistical analysis was performed using Mann-Whitney test
at the 0.05 significance level. Asteriks indicate a significant difference from WA-C.
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degradation products were also visible. This shows that
Inv is highly susceptible to gut protease cleavage even at
concentrations below physiological levels.
Interestingly several non-specific peptides (seen also for
the inv mutant in Figure 2) were also degraded by gut
proteases. To determine if the in vivo observed kinetics
of digestion could be reproduced in vitro, undiluted
human ileal secretions obtained by endoscopy from
patients were used to digest yersiniae grown in LB med-
ium. This experiment showed that full length Inv was
degraded to a 49 kDa peptide within about 2 h (Figure 3)
as was the case in the in vivo mouse experiment.
Serine proteases target invasion
To identify gut proteases that might be responsible for
the observed Inv degradation in vivo, we performed pro-
tease digests with in vitro grown yersiniae using trypsin,
a-chymotrypsin, pancreatic elastase, carboxypeptidase A
and pepsin. For this purpose 107 yersiniae were grown
at 27°C in LB medium, washed with PBS and digested
in their respective buffers for 2 h. Yersiniae were har-
vested by centrifugation and subjected to immunoblot-
ting with a polyclonal anti-Inv antiserum. In parallel
yersiniae were digested with small intestinal secretions
of Balb/c mice. These experiments showed that invasin
is degraded to a major 49 kDa peptide non-specifically
by multiple proteases such as trypsin, a-chymotrypsin,
elastase, and pepsin, but not by carboxypeptidase A
(Figure 4a). Digests with carboxypeptidase showed only
3 specific larger partial degradation products (ca. 60-80
kDa) that are also seen in the non digested control yer-
siniae. The slightly differing band pattern seen in Figure
4a vs. Figure 2 is due to incomplete digestion of the 55
kDa peptide seen in Figure 4. These partial digestion
products can also be seen in lanes 3 and 5 of Figure 2
when highly diluted (1:1000 and 1:10000) SI secretions
from mice were used for digests.
To determine if protease cleavage in the SI was due to
serine proteases, digests of yersiniae with SI secretions
were performed in the presence of a1 antitrypsin. These
experiments showed that degradation of Inv by SI secre-
tions could be inhibited by a serine protease inhibitor. As
can be seen in Figure 4b, full length Inv and a slightly
smaller spontaneous degradation product are completely
digested to the 49 and 25 kDa peptides only in the
absence of protease inhibitor. To determine if there were
differences in susceptibility to different proteases, digests
were performed with trypsin, a-chymotrypsin, and elas-
tase at concentrations between 0.001 μM - 10 μM. This
experiment revealed that Inv was most susceptible to
trypsin cleavage being completely degraded in 1 h at a
concentration of 0.1 μM followed by a-chymotrypsin and
elastase which are completely degraded at a concentra-
tion of 1 μM (results not shown).
YadA but not Myf is degraded by gut proteases
To determine if protease attack on Inv was a non-speci-
fic phenomenon, other surface proteins were studied by
Western blotting after treating yersiniae with SI secre-
tions or proteases (Figure 5). These experiments
revealed that YadA is also cleaved quite non-specifically
by several gut proteases such as trypsin a-chymotrypsin,
pepsin and elastase (but not carboxypeptidase A) at con-
centrations similar to those that cleave Inv. SI secretions
from mice as well as trypsin and pepsin completely
degraded YadA, whereas a-chymotrypsin and elastase
digests revealed 2 distinct degradation products (open
arrowheads in Figure 5). In contrast to YadA and Inv
however, Myf was not degraded by SI secretions or tryp-
sin, demonstrating that not all surface proteins are
degraded unspecifically in the gut.
Protease treated yersiniae are less invasive in vitro
To determine if gut protease attack on Yersinia is rele-
vant for the infection process, we performed adhesion
and invasion assays using HeLa cells. For these experi-
ments yersiniae lacking the virulence plasmid pYV were
digested with SI secretions or trypsin (0.23 μg/ml). Via-
bility of yersiniae after protease treatment was not com-
promised and verified by plating serial dilutions of
protease treated yersiniae. Tetracycline was added to
inhibit protein synthesis during cell culture experiments
(to inhibit new Inv expression). Yersiniae treated with
protease digestion buffer were used as controls. These
experiments revealed that yersiniae pre-treated with SI
secretions or trypsin were much less invasive (similar to
an inv mutant) than yersiniae treated with trypsin diges-
tion buffer. Furthermore protease digested yersiniae
were much less adherent to HeLa cells than control bac-
teria (Figure 6) as expected.
Discussion
While passing through the GI tract enteropathogenic
bacteria are subjected to many adverse conditions such
as the acidity of the stomach, antimicrobial peptides and
gut proteases. The relevance of most of these factors in
killing or inhibiting bacteria has been demonstrated
[23,24,32]. However there are no reports of the effects
of gut proteases on surface exposed virulence factors of
enteric pathogens. We therefore studied the role of gut
proteases on surface exposed virulence factors of Yersi-
nia such as Inv, YadA, and Myf.
It has previously been demonstrated that only very few
yersiniae invade Peyer’s patches from the gut lumen
resulting in the formation of very few monoclonal
microabscesses [3,33]. The host has been shown to
severely restrict the sequential invasion of Peyer’s
patches by yersiniae [3] which obviously contributes to
the low number of yersiniae invading and abscessing
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PPs. But the low frequency with which Yersinia initially
establishes abscesses in PPs cannot be explained by this
mechanism. Since Inv is a surface located protein we
postulated that Inv is attacked by gut proteases in the
small intestine which would prevent interaction of yersi-
niae with b-integrins of M cells. To investigate the fate
of invasin at very early time-points after infection, we
orally infected mice with Y. enterocolitica and analysed
Inv production by Western blotting in the small intes-
tines of mice. The 92 kDa full length Inv protein of yer-
siniae grown at 27°C was still detectable in the small
intestine shortly after oral infection but was rapidly
degraded in vivo. Only 30 min after oral infection a sig-
nificant amount of invasin was degraded to a ca. 49 kDa
protein with only this degradation product and no full
length Inv remaining after 2.5 h. As reported previously,
Inv was not detectable in the SI lumen between 2 and 5
days after oral infection [3]. These results indicate that
this major invasion factor of Yersinia is degraded within
a few hours after oral uptake by gut proteases and is no
longer available to mediate invasion of PPs. Of course
other factors such as pH, gut-microbiota and other gut-
environmental factors could also cause similar effects.
Not surprisingly the invasion capacity of yersiniae for
epithelial cells was greatly reduced when they were trea-
ted with trypsin or SI fluid prior to infection of HeLa
cells. There is currently no suitable cell culture model
to study invasion of M-cells in vitro and HeLa cells may
not necessarily represent a suitable model for M cell
invasion. Therefore it will be interesting to study the
effects of gut proteases on the invasion of PPs in vivo. It
is of course possible that in vivo yersiniae might be pro-
tected from the action of intestinal proteases in certain
niches. They could for example be protected by intest-
inal mucus or might produce a biofilm in the gut. Possi-
bly Inv could be protected from digestion by other
Yersinia surface proteins such as YadA or Myf.
Proteolytic cleavage of Inv in vitro showed 3 distinct
degradation products that were associated with yersi-
niae. We attempted to identify these degradation pro-
ducts in membrane preparations of Yersinia by MALDI-
TOF but this was not possible since digested Inv pep-
tides were not released into the supernatant and mem-
brane preparations of Yersinia contained many proteins
of similar size. We were, however, successful in identify-
ing cleavage products by MALDI-TOF and protein
sequencing using a recombinant protein consisting of
397 C terminal amino acids of Inv [34]. However, these
peptides were distinct from those that were generated
by digesting whole bacteria. Nevertheless, since the Inv
antibody that we used is directed against domains D1-
D5 of Inv, the major degradation product of about 49
kDA that was observed in yersiniae washed from the SI
of mice must represent the Inv membrane anchor with
part of the D1 domain still intact.
Besides Inv we demonstrated that other surface pro-
teins of Yersinia such as YadA are also readily degraded
by gut proteases. However, protease attack on surface
proteins does not seem to be a general phenomenon
since MyfA which forms fibrillae on the Yersinia surface
extending 2 microns [20] is not degraded by similar
concentrations of trypsin or small intestinal fluid.
Gut proteases could have several effects on invasins
and adhesins of bacteria. It is possible that such factors
are activated by proteolysis. This has been shown for
reovirus where luminal proteolytic digestion was impor-
tant for rendering progeny virions infectious in the gut
[35]. Alternatively, proteolysis of such adhesion factors
might lead to inactivation and protect the host from
hyperinvasion by Yersinia. Furthermore, proteolysis of
invasins and adhesins could promote bacterial spreading
to new hosts by increasing shedding of yersiniae in
feces.
Conclusions
Yersinia virulence factors such as invasin are targeted by
gut proteases in the lumen of the small intestine. Inva-
sin, the most important invasion factor for Peyer’s
patches is rapidly degraded in the small intestine within
2-3 h after oral infection of mice and is therefore no
longer available to mediate invasion of Peyer’s patches.
This is consistent with the finding that Yersinia invasion
occurs very early during the infection process and might
contribute to the low numbers of yersiniae reaching
Peyer’s patches after oral infection of mice.
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